News for 'drug money'

'We Are Voting For The Next Chief Minister'

'We Are Voting For The Next Chief Minister'

Rediff.com27 Sep 2024

A land-owning class, the Jats are a powerful community and account for 28 per cent of Haryana's population. The time, they believe, has now come for them to take revenge.

Electronics exports propelled by mobile show sharpest surge in top 10 club

Electronics exports propelled by mobile show sharpest surge in top 10 club

Rediff.com3 Jan 2024

Exports of electronics goods has risen by 24 per cent from April to November as compared with the same period in the last fiscal, the largest increase out of India's top 10 export categories. The increase has been propelled by mobile exports under the Production Linked Incentive (PLI) scheme and has pushed electronics up from sixth to fifth position in the top 10. A gap of $200 million separates electronics from occupying the fourth position, currently held by drugs and pharmaceuticals at $17.9 billion.

India's exports rise 11.9% in Feb, highest in 11 months

India's exports rise 11.9% in Feb, highest in 11 months

Rediff.com15 Mar 2024

India recorded the highest monthly exports during the fiscal in February, registering an 11.9 per cent growth to $41.4 billion, mainly driven by increased shipments of engineering goods, electronic items and pharma products. The trade deficit during February worked out to $18.7 billion, up from $16.57 billion in the year-ago month, as gold imports surged significantly. Merchandise imports were valued at $60.11 billion, up 12.16 per cent compared to $53.58 per cent in February 2023.

Advertisers feel the heat of Bollywood drug abuse probe

Advertisers feel the heat of Bollywood drug abuse probe

Rediff.com1 Oct 2020

Advertising agencies admitted that conversations had begun with their clients to exercise restraint while using brand endorsements featuring film actors whose names appeared in the probe.

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

Rediff.com20 Jul 2020

The Drug Controller General of India has sent a letter to the Glenmark seeking clarifications on pricing as well as claims of therapeutic efficacy. While Glenmark has claimed this drug is effective in comorbid conditions like diabetes, hypertension, according to protocol summary (of clinical trials) the trial was not designed to access the Fabiflu in comorbid conditions.

Doval moots interoperability among central police forces

Doval moots interoperability among central police forces

Rediff.com24 May 2024

National security advisor Ajit Doval on Friday suggested that various central armed police forces of the country should have "jointness" and interoperability among themselves like the ongoing plan for the defence forces.

HSBC's money laundering lapses, by the numbers

HSBC's money laundering lapses, by the numbers

Rediff.com7 Dec 2012

Bank has apologised and vowed it has recently overhauled its anti-money-laundering efforts.

'BJP Has 6,000 Crores To Spend On Elections'

'BJP Has 6,000 Crores To Spend On Elections'

Rediff.com19 Apr 2024

'Not even a single rupee from the electoral bonds should be allowed to be used in the election.' 'If it is used in the election, it will taint India's electoral process itself.'

India's exports dip marginally in March; 3.11% in FY24

India's exports dip marginally in March; 3.11% in FY24

Rediff.com15 Apr 2024

India's merchandise exports dipped marginally in March to $41.69 billion, and by 3.11 per cent during the last fiscal year to $437.06 billion mainly due to continued geopolitical turmoil, and depressed global trade. Imports, too, declined in March as well during the entire 2023-24. Trade deficit, or the gap between imports and exports, narrowed 17.74 per cent in March to $15.6 billion and came down 9.33 per cent to $240.17 billion in FY24.

Regulatory woes torpedo PE/VC deals in e-pharma sector

Regulatory woes torpedo PE/VC deals in e-pharma sector

Rediff.com27 Jun 2023

With regulatory uncertainties clouding the future of online pharmacies, deals in the space are showing signs of slowdown, as also fresh investment from private-equity (PE) firms and venture capitalists (VCs). The data from Venture Intelligence shows so far in 2023 (as of June 13) there has been one deal with PE-VC funding. In 2022 there were four, a sharp fall from the 12, totalling $1,520 million, the sector had attracted in 2021.

Court finds no 'reasonable grounds' to not link Rhea to drug case

Court finds no 'reasonable grounds' to not link Rhea to drug case

Rediff.com15 Sep 2020

'The investigation is at preliminary stage, therefore, from the available record, it can not be said that there are no reasonable grounds to connect the accused (Rhea) (to the case),' the court observed. The court also said there is possibility of the accused tampering with evidence if released on bail.

Who Will Vote For Vijay, And Why?

Who Will Vote For Vijay, And Why?

Rediff.com14 Aug 2024

Where do Vijay and his TVK expect to get their votes from? Vijay has a huge fan following among women, but will they automatically become his voters like they had done for MGR's AIADMK, asks N Sathiya Moorthy.

Kejriwal stopped taking insulin before his arrest: Tihar officials

Kejriwal stopped taking insulin before his arrest: Tihar officials

Rediff.com20 Apr 2024

The Delhi minister also claimed that Kejriwal used to take 50 units of insulin daily before he was sent to jail.

'Power shifts to chemists instead of doctors'

'Power shifts to chemists instead of doctors'

Rediff.com22 Aug 2023

'Whichever company offers better incentives, the chemist would prefer it.'

AAP, Cong spar over Punjab MLA's arrest in 2015 case

AAP, Cong spar over Punjab MLA's arrest in 2015 case

Rediff.com28 Sep 2023

Congress MLA Sukhpal Singh Khaira was arrested by the Punjab Police in connection with a 2015 drugs case on Thursday morning, official sources said.

Medical devices to be treated as drugs from next fiscal

Medical devices to be treated as drugs from next fiscal

Rediff.com12 Feb 2020

The new regime aims to bring in ease of doing business, as the NITI Aayog has proposed to do away with the need to have manufacturing licences to register medical devices or to get a certificate of compliance.

Quality perceptions hobble Jan Aushadi drugs

Quality perceptions hobble Jan Aushadi drugs

Rediff.com10 Oct 2018

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.

How Canada is 'soft peddling' Khalistani extremists

How Canada is 'soft peddling' Khalistani extremists

Rediff.com26 Sep 2023

Over the years, Khalistani extremists were further "emboldened" and started "operating with impunity" from Canada.

What is Schedule M and why it's mandatory for all pharma units

What is Schedule M and why it's mandatory for all pharma units

Rediff.com12 Jul 2023

With an eye on improving quality assurance in the wake of increased global scrutiny on Indian pharma products, the Centre on Tuesday said that Schedule M of the Drugs and Cosmetics Act, 1940 will be made compulsory for small and medium scale manufacturers in a phased manner. Union Health Minister Mansukh Mandaviya has asked micro-small and medium enterprises in pharma manufacturing to move towards good manufacturing practices (GMP) through self regulation. "This will help in quality assurance and also reduce compliance burden," Mandaviya.

Why Nagaland Is Baying For Army's Blood

Why Nagaland Is Baying For Army's Blood

Rediff.com25 Jul 2024

'It is in the interest of China and Pakistan to give a bad name to the Indian Army and remove AFSPA 'completely' from the north east.' 'Hopefully, better sense will prevail and the ground realities of the army countering insurgency in the north east acknowledged,' asserts Lieutenant General Prakash Katoch (retd).

Price relief for diabetes patients as drugs go off patent

Price relief for diabetes patients as drugs go off patent

Rediff.com13 Jan 2020

At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category of drugs - SGLT-2 inhibitors or gliflozins.

'Depending on the product, the pricing pressure will always be there'

'Depending on the product, the pricing pressure will always be there'

Rediff.com3 Jun 2024

'That is a significant milestone for us and something we aspired for.'

As domestic sales decline, drug makers focus on exports

As domestic sales decline, drug makers focus on exports

Rediff.com1 Oct 2020

While sales in the domestic market declined 4.2 per cent during the April-July period, exports grew steadily at 9.5 per cent during the same period.

Heeramandi Leads May's OTT Releases

Heeramandi Leads May's OTT Releases

Rediff.com29 Apr 2024

May offers a mix of original Web series and digital movie premieres on OTT.

Electoral Bonds: The Quid Pro Quo Factor

Electoral Bonds: The Quid Pro Quo Factor

Rediff.com3 Apr 2024

Which entrepreneur would willingly part with her or his hard-earned money for grasping, self-serving politicians? asks Debashis Basu.

Weak Q4 may be rare bitter pill for Sun Pharma

Weak Q4 may be rare bitter pill for Sun Pharma

Rediff.com31 May 2024

Sun Pharmaceutical Industries reported a 34 per cent year-on-year (Y-o-Y) jump in net profit to Rs 2,654.6 crore in Q4FY24.

After April shock, drug sales improve in May

After April shock, drug sales improve in May

Rediff.com20 May 2020

The industry feels two factors have played a role in improving the offtake and reducing trade inventory - one is that the supply chain in pharmaceuticals has more or less stabilised, and secondly, with lockdown curbs easing and OPDs opening, some demand has grown at the consumer end as well.

How govt plans to push generic drugs

How govt plans to push generic drugs

Rediff.com20 Mar 2018

The change in labelling, which is seen as a part of government's effort to push generic drugs, will come into effect from September 13.

A bitter pill for Aurobindo's sterile drug unit

A bitter pill for Aurobindo's sterile drug unit

Rediff.com25 Nov 2019

USFDA issues Form 483 with as many as 14 observations that could impact ongoing operations at Aurobindo's Pashamailaram facility in Hyderabad.

Mexican drug lord 'El Chapo' found guilty; faces life in prison

Mexican drug lord 'El Chapo' found guilty; faces life in prison

Rediff.com13 Feb 2019

Joaquin "El Chapo" Guzman Loera was convicted on numerous counts including money laundering, engaging in a continuing criminal enterprise, distribution of heroin and cocaine and other drugs, and illegal arms possession.

How govt plans to ensure faster availability of new drugs

How govt plans to ensure faster availability of new drugs

Rediff.com16 Dec 2019

Concerned about the rise of antibiotic resistance and the time it takes for drugs developed abroad to reach Indians, the government is considering holding its own clinical trials. Clinical trials for new drugs have so far primarily been conducted only by private Indian or foreign drug firms. But given the stringent nature of India's regulatory environment for clinical trials, several pharmaceutical companies have moved their trials out of India. As a result, only 1.2 per cent of global clinical trials take place in India.

Madras HC stays online sale of drugs

Madras HC stays online sale of drugs

Rediff.com31 Oct 2018

ustice R Mahadevan passed the interim order on a plea moved by the Chennai-based Tamil Nadu Chemists & Druggists Association seeking a direction to authorities concerned to block the links of websites that selling medicines online.

Aurobindo Pharma: Strong prospects offset by valuation concerns

Aurobindo Pharma: Strong prospects offset by valuation concerns

Rediff.com2 Nov 2023

Since the start of this financial year (FY24), the stock of Aurobindo Pharma has been one of the top pharma gainers, enhancing investor wealth by over 68 per cent, with a third of those gains coming in the last three months. The stock is riding on multiple triggers given its investments in the production-linked incentive or PLI scheme, biosimilars, injectables and vaccines, which should drive revenues and profits over the medium term. Better than expected performance after the June quarter results led to a revision of earnings estimates for FY24 and FY25.

Indian pharma exports to Iran decline thanks to its lower rupee reserves

Indian pharma exports to Iran decline thanks to its lower rupee reserves

Rediff.com3 Oct 2023

India's pharmaceutical exports to Iran have been hit owing to depleting rupee reserves in the West Asian country because of India stopping the import of crude oil from it in 2019 following US sanctions. Pharmaceutical exports dropped 71.25 per cent in April-August this year over the same period last year. The data from the Pharmaceutical Exports Promotion Council (Pharmexcil) showed exports to Iran had declined 31.29 per cent in 2022-23 as against the previous financial year.

328 fixed-dose combination drugs banned on safety grounds

328 fixed-dose combination drugs banned on safety grounds

Rediff.com14 Sep 2018

The original list had named 349 drugs, but 15 drugs, approved prior to 1988, have been kept outside the purview of the ban

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

Rediff.com5 Aug 2020

Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease.

FSSAI launches probe into MDH and Everest products

FSSAI launches probe into MDH and Everest products

Rediff.com23 Apr 2024

The Food Safety and Standards Authority of India (FSSAI) has commissioned a quality check on MDH and Everest products. This follows complaints that several popular spice mixes of the two leading brands contained traces of ethylene oxide more than the permissible levels, official sources said. This move by FSSAI comes after Hong Kong and Singapore recalled variants of the two masala majors' products in their countries.

Asiad medal winners the GOAT for the country: Modi

Asiad medal winners the GOAT for the country: Modi

Rediff.com10 Oct 2023

Prime Minister Narendra Modi assured all possible help to Indian athletes in their endeavour to achieve greater heights and expressed confidence that the country will better its Hangzhou performance in the next edition of the Asian Games.

Pharma stocks rally on lower price erosion, hopes of US generic mkt uptick

Pharma stocks rally on lower price erosion, hopes of US generic mkt uptick

Rediff.com9 Jul 2023

The BSE Healthcare Index is up 19 per cent as compared to BSE Sensex returns of 11 per cent during this period. Nitin Agarwal of DAM Capital highlighted this trend in a report last month. "After a sustained period of underperformance over FY21-23, the BSE Healthcare Index has once again captured the spotlight. "The recent uptick in performance has been driven by hospitals and emerging green shoots in pharmaceutical exports, particularly to the US, along with sustaining momentum in domestic branded formulations," he said.

'APIs are a very strategic part of Biocon's business'

'APIs are a very strategic part of Biocon's business'

Rediff.com7 Jan 2024

'There is no reason why we should break this business up.'